Jenburkt Pharmaceuticals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	347.36	320.61	259.77	246.07	222.97
Depreciation & Amortization	31.08	25.2	20.63	21.28	17
Other Amortization	-	2.08	2.77	1.31	1.98
Loss (Gain) From Sale of Assets	0.45	0.34	0.19	0.49	-0.33
Loss (Gain) From Sale of Investments	-5.26	-8.58	-1.33	-0.04	-0.02
Provision & Write-off of Bad Debts	-18.68	0.79	12.88	5.93	0.84
Other Operating Activities	-59.82	-66.32	-31.5	-44.02	-41.82
Change in Accounts Receivable	-10.44	-11.45	-36.86	-15.87	-10.45
Change in Inventory	-47.53	-3.19	-2.24	15.5	-23.06
Change in Accounts Payable	-0.56	18.98	1.6	-10.14	25.18
Change in Other Net Operating Assets	28.6	0.6	-144.68	-49.99	-99.57
Operating Cash Flow	265.22	279.06	81.24	170.52	92.71
Operating Cash Flow Growth	-4.96%	243.51%	-52.36%	83.92%	-52.34%
Capital Expenditures	-137.17	-197.14	-25.54	-21.05	-30.54
Sale of Property, Plant & Equipment	0.08	-	-	0	5.06
Investment in Securities	-75.17	1,501	1,204	31.84	-37.3
Other Investing Activities	17.76	-1,474	-1,184	15.38	50.75
Investing Cash Flow	-194.5	-170.45	-5.8	26.18	-12.02
Long-Term Debt Repaid	-6.4	-5.61	-5.1	-5.1	-5.1
Net Debt Issued (Repaid)	-6.4	-5.61	-5.1	-5.1	-5.1
Repurchase of Common Stock	-	-	-	-145.15	-
Common Dividends Paid	-79.39	-67.81	-63.18	-55	-46.8
Other Financing Activities	-2.8	-2.8	-2.5	-5.17	-3.41
Financing Cash Flow	-88.59	-76.22	-70.78	-210.41	-55.31
Net Cash Flow	-17.88	32.39	4.66	-13.71	25.38
Free Cash Flow	128.05	81.92	55.7	149.48	62.17
Free Cash Flow Growth	56.30%	47.09%	-62.74%	140.43%	-66.05%
Free Cash Flow Margin	7.15%	5.40%	3.92%	10.93%	5.01%
Free Cash Flow Per Share	29.02	18.56	12.62	32.74	13.55
Cash Interest Paid	-	2.8	2.5	5.16	3.41
Cash Income Tax Paid	-	134.33	82.63	82.24	75.61
Levered Free Cash Flow	184.28	87.39	182.75	131.18	143.35
Unlevered Free Cash Flow	187.17	89.76	184.19	133.05	145.52
Change in Working Capital	-29.92	4.94	-182.17	-60.5	-107.91

Source: S&P Global Market Intelligence. Standard template. Financial Sources.